This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Brigham & Women's Hospital, Inc. The contract, part of the NCI Cancer Genome Atlas Program Tissue Purchase, procures tissue samples and associated data from various cancer types to support the Cancer Genome Atlas (TCGA) program. The contract has a ceiling value of $276,000 and does not contain any small business set-aside designations.
Under this contract, Brigham & Women's Hospital, a major academic medical center and research institution, has been issued at least one firm-fixed-price delivery order valued at $63,000 to recover tissue samples and data from multiple cancer types for the TCGA program. This supports the NCI's efforts to advance scientific knowledge and improve patient care through federally-funded biomedical and clinical research. Brigham & Women's Hospital has extensive experience executing federal contract and grant awards across a wide range of medical specialties, making it well-suited to provide the specialized tissue procurement and data collection services required under this IDV.
Generated 11/24/24, 9:11 AM